ATAI vs IBM · rev $4.1M vs P/E 25, rev $17.16B
ATAI Life Sciences BV (ATAI) versus International Business Machines (IBM) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
ATAI currently screens at market cap $555.8M. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Not investment advice. Open the ATAI and IBM stock pages for the full models.
Not investment advice.